Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Durvalumab”

711 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 711 results

Not applicableLooking for participantsNCT05667064
What this trial is testing

Imfinzi/Imjudo uHCC Japan PMS _ Japan Post-Marketing Surveillance (PMS) Study

Who this might be right for
Unresectable Hepatocellular Carcinoma
AstraZeneca 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05943106
What this trial is testing

BCG in Combination With Durvalumab in Adult BCG-naïve, High-risk NMIBC Participants

Who this might be right for
Non-Muscle- Invasive Bladder Cancer
AstraZeneca 100
Large-scale testing (Phase 3)Active Not RecruitingNCT04380636
What this trial is testing

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Who this might be right for
Lung NeoplasmsCarcinoma, Non-Small-Cell Lung
Merck Sharp & Dohme LLC 870
Early research (Phase 1)Study completedNCT03635164
What this trial is testing

Radiotherapy With Durvalumab Prior to Surgical Resection for HPV Negative Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
University of Colorado, Denver 21
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07332351
What this trial is testing

Neoadjuvant Intravesical Nadofaragene Firadenovec With Gemcitabine, Cisplatin and Durvalumab for the Treatment of Muscle Invasive Bladder Cancer, TRIFECTA Trial

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaStage II Bladder Cancer AJCC v8Stage IIIA Bladder Cancer AJCC v8
University of Washington 33
Large-scale testing (Phase 3)Looking for participantsNCT05255653
What this trial is testing

Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

Who this might be right for
Endometrial Cancer
Leiden University Medical Center 1,615
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06650709
What this trial is testing

NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study

Who this might be right for
Ovarian Cancer Stage IV
British Columbia Cancer Agency 40
Testing effectiveness (Phase 2)Looking for participantsNCT06708858
What this trial is testing

Phase Ⅱ Clinical Study of Surufatinib Combined With Gemcitabine and Cisplatin Plus Durvalumab/Pembrolizumab Regimen in the Treatment of Advanced Biliary Tract Cancer

Who this might be right for
Advanced Biliary Tract Cancer
Dai, Guanghai 35
Testing effectiveness (Phase 2)Study completedNCT04115111
What this trial is testing

Diadem to Investigate the Activity and Safety of Durvalumab

Who this might be right for
Pleura Mesothelioma
Mario Negri Institute for Pharmacological Research 57
Testing effectiveness (Phase 2)Active Not RecruitingNCT02888743
What this trial is testing

Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer

Who this might be right for
Metastatic Colorectal CarcinomaMetastatic Lung Non-Small Cell CarcinomaStage IV Colorectal Cancer AJCC v7+3 more
National Cancer Institute (NCI) 110
Not applicableStudy completedNCT03643484
What this trial is testing

IMFINZI Specific-Clinical Experience Investigation in Patients With NSCLC After Definitive Chemoradiation Therapy

Who this might be right for
Carcinoma, Non-Small-Cell Lung
AstraZeneca 634
Testing effectiveness (Phase 2)UnknownNCT05034133
What this trial is testing

Durvalumab With Chemotherapy Followed by Sequential Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited Stage Small Cell Lung Cancer
Beijing Haidian Hospital 20
Large-scale testing (Phase 3)Ended earlyNCT05223647
What this trial is testing

Chemo-immunotherapy Plus Thoracic Radiotherapy in Extensive Stage Small-cell Lung Cancer

Who this might be right for
Small-cell Lung Cancer
Norwegian University of Science and Technology 239
Testing effectiveness (Phase 2)UnknownNCT04054518
What this trial is testing

Durvalumab as Maintenance Following Chemoradiation for Unresectable Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma
Tiago Biachi 22
Large-scale testing (Phase 3)Active Not RecruitingNCT05043090
What this trial is testing

Savolitinib Plus Durvalumab Versus Sunitinib and Durvalumab Monotherapy in MET-Driven, Unresectable and Locally Advanced or Metastatic PRCC

Who this might be right for
Papillary Renal Cell Carcinoma
AstraZeneca 148
Testing effectiveness (Phase 2)Study completedNCT02643303
What this trial is testing

Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers

Who this might be right for
Head and Neck Squamous Cell CarcinomaBreast CancerSarcoma+8 more
Ludwig Institute for Cancer Research 58
Early research (Phase 1)Active Not RecruitingNCT02546661
What this trial is testing

Open-Label, Randomised, Multi-Drug, Biomarker-Directed, Phase 1b Study in Pts w/ Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder Cancer
AstraZeneca 117
Early research (Phase 1)Study completedNCT02027961
What this trial is testing

Phase 1 Safety and Tolerability of MEDI4736 in Combination With Dabrafenib and Trametinib or With Trametinib Alone

Who this might be right for
Melanoma
MedImmune LLC 68
Large-scale testing (Phase 3)Not Yet RecruitingNCT07361497
What this trial is testing

Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb 850
Testing effectiveness (Phase 2)Active Not RecruitingNCT03579784
What this trial is testing

Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer

Who this might be right for
Advanced Gastric Cancer
Do-Youn Oh 40
Load More Results